Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibition (Englisch)
- Neue Suche nach: Ferrucci, V.
- Neue Suche nach: de Antonellis, P.
- Neue Suche nach: Pennino, F. P.
- Neue Suche nach: Asadzadeh, F.
- Neue Suche nach: Virgilio, A.
- Neue Suche nach: Montanaro, D.
- Neue Suche nach: Galeone, A.
- Neue Suche nach: Boffa, I.
- Neue Suche nach: Pisano, I.
- Neue Suche nach: Scognamiglio, I.
- Neue Suche nach: Ferrucci, V.
- Neue Suche nach: de Antonellis, P.
- Neue Suche nach: Pennino, F. P.
- Neue Suche nach: Asadzadeh, F.
- Neue Suche nach: Virgilio, A.
- Neue Suche nach: Montanaro, D.
- Neue Suche nach: Galeone, A.
- Neue Suche nach: Boffa, I.
- Neue Suche nach: Pisano, I.
- Neue Suche nach: Scognamiglio, I.
In:
BRAIN
;
141
, 5
;
1300-1319
;
2018
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibition
-
Beteiligte:Ferrucci, V. ( Autor:in ) / de Antonellis, P. ( Autor:in ) / Pennino, F. P. ( Autor:in ) / Asadzadeh, F. ( Autor:in ) / Virgilio, A. ( Autor:in ) / Montanaro, D. ( Autor:in ) / Galeone, A. ( Autor:in ) / Boffa, I. ( Autor:in ) / Pisano, I. ( Autor:in ) / Scognamiglio, I. ( Autor:in )
-
Erschienen in:BRAIN ; 141, 5 ; 1300-1319
-
Verlag:
- Neue Suche nach: Oxford University Press
-
Erscheinungsdatum:01.01.2018
-
Format / Umfang:20 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.8
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.8 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 141, Ausgabe 5
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1235
-
EditorialKullmann, D. M. et al. | 2018
- 1236
-
The snowball effect of RNA binding protein dysfunction in amyotrophic lateral sclerosisFratta, P. / Isaacs, A. M. et al. | 2018
- 1239
-
Functional ‘unlocking’: bedside detection of covert awareness after severe brain damageBoly, M. / Laureys, S. et al. | 2018
- 1241
-
Is longitudinal tau PET ready for use in Alzheimer’s disease clinical trials?Hansson, O. / Mormino, E. C. et al. | 2018
- 1244
-
Disease progression models for dominantly-inherited Alzheimer’s diseaseLi, D. / Donohue, M. C. et al. | 2018
- 1247
-
Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementiaWalker, C. / El-Khamisy, S. F. et al. | 2018
- 1263
-
Neurotransmitter deficits from frontotemporal lobar degenerationMurley, A. G. / Rowe, J. B. et al. | 2018
- 1286
-
Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegiaNewton, T. / Allison, R. / Edgar, J. R. / Lumb, J. H. / Rodger, C. E. / Manna, P. T. / Rizo, T. / Kohl, Z. / Nygren, A. O. / Arning, L. et al. | 2018
- 1300
-
Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1–TGF-β–OTX2–SNAIL via PTEN inhibitionFerrucci, V. / de Antonellis, P. / Pennino, F. P. / Asadzadeh, F. / Virgilio, A. / Montanaro, D. / Galeone, A. / Boffa, I. / Pisano, I. / Scognamiglio, I. et al. | 2018
- 1320
-
TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosisDeshaies, J. E. / Shkreta, L. / Moszczynski, A. J. / Sidibé, H. / Semmler, S. / Fouillen, A. l. / Bennett, E. R. / Bekenstein, U. / Destroismaisons, L. / Toutant, J. et al. | 2018
- 1334
-
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early interventionvan Langelaar, J. / van der Vuurst de Vries, R. M. / Janssen, M. / Wierenga-Wolf, A. F. / Spilt, I. M. / Siepman, T. A. / Dankers, W. / Verjans, G. M. / de Vries, H. E. / Lubberts, E. et al. | 2018
- 1350
-
Protein instability, haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathyKovačević, J. / Maroteaux, G. / Schut, D. / Loos, M. / Dubey, M. / Pitsch, J. / Remmelink, E. / Koopmans, B. / Crowley, J. / Cornelisse, L. N. et al. | 2018
- 1375
-
Disrupted dynamic network reconfiguration of the language system in temporal lobe epilepsyHe, X. / Bassett, D. S. / Chaitanya, G. / Sperling, M. R. / Kozlowski, L. / Tracy, J. I. et al. | 2018
- 1390
-
KEAP1 inhibition is neuroprotective and suppresses the development of epilepsyShekh-Ahmad, T. / Eckel, R. / Dayalan Naidu, S. / Higgins, M. / Yamamoto, M. / Dinkova-Kostova, A. T. / Kovac, S. / Abramov, A. Y. / Walker, M. C. et al. | 2018
- 1404
-
Characterization of EEG signals revealing covert cognition in the injured brainCurley, W. H. / Forgacs, P. B. / Voss, H. U. / Conte, M. M. / Schiff, N. D. et al. | 2018
- 1422
-
Artificial limb representation in amputeesvan den Heiligenberg, F. M. / Orlov, T. / Macdonald, S. N. / Duff, E. P. / Henderson Slater, D. / Beckmann, C. F. / Johansen-Berg, H. / Culham, J. C. / Makin, T. R. et al. | 2018
- 1434
-
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtinGalvan, L. / Francelle, L. / Gaillard, M. C. / de Longprez, L. / Carrillo-de Sauvage, M. A. / Liot, G. r. / Cambon, K. / Stimmer, L. / Luccantoni, S. / Flament, J. et al. | 2018
- 1455
-
Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson’s diseaseLe Heron, C. / Plant, O. / Manohar, S. / Ang, Y. S. / Jackson, M. / Lennox, G. / Hu, M. T. / Husain, M. et al. | 2018
- 1470
-
Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s diseaseNakamura, A. / Cuesta, P. / Fernández, A. / Arahata, Y. / Iwata, K. / Kuratsubo, I. / Bundo, M. / Hattori, H. / Sakurai, T. / Fukuda, K. et al. | 2018
- 1486
-
Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageingChhatwal, J. P. / Schultz, A. P. / Johnson, K. A. / Hedden, T. / Jaimes, S. / Benzinger, T. L. / Jack, C. / Ances, B. M. / Ringman, J. M. / Marcus, D. S. et al. | 2018
- 1501
-
Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson’s diseaseSchulz, J. / Pagano, G. / Fernández Bonfante, J. A. / Wilson, H. / Politis, M. et al. | 2018
- 1517
-
Longitudinal tau PET in ageing and Alzheimer’s diseaseJack, C. R. / Wiste, H. J. / Schwarz, C. G. / Lowe, V. J. / Senjem, M. L. / Vemuri, P. / Weigand, S. D. / Therneau, T. M. / Knopman, D. S. / Gunter, J. L. et al. | 2018
- 1529
-
Data-driven models of dominantly-inherited Alzheimer’s disease progressionOxtoby, N. P. / Young, A. L. / Cash, D. M. / Benzinger, T. L. / Fagan, A. M. / Morris, J. C. / Bateman, R. J. / Fox, N. C. / Schott, J. M. / Alexander, D. C. et al. | 2018
- 1545
-
A neurocomputational account of reward and novelty processing and effects of psychostimulants in attention deficit hyperactivity disorderSethi, A. / Voon, V. / Critchley, H. D. / Cercignani, M. / Harrison, N. A. et al. | 2018
- 1558
-
Altruistic decisions following penetrating traumatic brain injuryMoll, J. / de Oliveira-Souza, R. / Basilio, R. / Bramati, I. E. / Gordon, B. / Rodríguez-Nieto, G. / Zahn, R. / Krueger, F. / Grafman, J. et al. | 2018
- 1570
-
How the coming of the NHS changed British neurologyShorvon, S. et al. | 2018
- e36
-
The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspotYan, H. / Kubisiak, T. / Ji, H. / Xiao, J. / Wang, J. / Burmeister, M. et al. | 2018
- e37
-
Reply: The recurrent mutation in TMEM106B also causes hypomyelinating leukodystrophy in China and is a CpG hotspotSimons, C. / Dyment, D. / van der Knaap, M. S. / Wolf, N. I. et al. | 2018
- e38
-
Towards personalized therapy for multiple sclerosis: limitations of observational dataSteyerberg, E. W. / Claggett, B. et al. | 2018
- e39
-
Reply: Towards personalized therapy for multiple sclerosis: limitations of observational dataKalincik, T. et al. | 2018
- e40
-
Noisy but not placebo: defining metrics for effects of neurofeedbackWitte, M. / Kober, S. E. / Wood, G. et al. | 2018
- e41
-
Reply: Noisy but not placebo: defining metrics for effects of neurofeedbackSchabus, M. et al. | 2018
- e42
-
Corrigendum| 2018